Clinical trial Recruiting at 1 site Interventional

Virtual Cognitive Behavioral Therapy for Insomnia in Cancer Survivors

Official title: Efficacy of Synchronous, Virtual Cognitive Behavioral Therapy for Insomnia Across Phases of Cancer Survivorship

Run by Massachusetts General Hospital · NCT06807086 · Data updated 2026-11-12

This study is testing a virtual therapy program for insomnia to see if it helps cancer survivors sleep better compared to regular care.

Quick facts

Study typeInterventional
SexAll
Enrollment198 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Drugs / interventionschemotherapy, radiation
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedJanuary 1, 2025
Main results expectedJanuary 31, 2028
Study endsDecember 28, 2028
Registry record updatedMarch 13, 2026
Trial IDNCT06807086 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include cancer survivors aged 18 and older who experience chronic insomnia and are either in treatment or have completed primary cancer treatment.

Probably not a fit

Patients with untreated non-insomnia sleep disorders or serious mental illnesses may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project evaluates the effectiveness of a virtual Cognitive Behavioral Therapy for Insomnia (CBT-I) program, known as the Survivorship Sleep Program, compared to Enhanced Usual Care in reducing insomnia severity among cancer survivors. The trial will include 198 participants and assess both subjective and objective sleep measures, emotional distress, fatigue, and medication use. It aims to include a diverse group of cancer survivors, including those currently in treatment and those living with metastatic cancer, to enhance the generalizability of the findings. The study will utilize both quantitative and qualitative methods to gather comprehensive data on the impact of the intervention.

Why it matters

Potential benefit: If successful, this program could significantly improve sleep quality and overall well-being for cancer survivors suffering from insomnia.

How similar studies have gone: Previous pilot studies have shown the feasibility and preliminary efficacy of similar CBT-I approaches for cancer survivors, indicating potential for success in this larger trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Cancer survivor, defined as:

   1. (A) history of nonmetastatic, localized or regional, solid or blood malignancy(ies) and completion of primary cancer treatment (i.e., radiation, surgery, and/or chemotherapy). Use of hormonal, maintenance, oral, and immunotherapies is permitted; or
   2. (B) history of nonmetastatic, localized or regional, solid or blood malignancy(ies) and current primary cancer treatment (i.e., radiation, surgery, and/or chemotherapy); Use of hormonal, maintenance, oral, and immunotherapies is permitted; or
   3. (C) history of metastatic sold or blood malignancy (ies) taking hormonal, maintenance, oral, or immunotherapies to prevent further disease progression.
2. Chronic insomnia (DSM-5 criteria)
3. Age 18 years or older

Exclusion Criteria:

1. Self-reported inability to speak and write in English
2. Undertreated non-insomnia sleep disorder (e.g., sleep apnea)
3. Undertreated epilepsy, undertreated serious mental illness, undertreated suicidality, and/or psychiatric hospitalization in the past year
4. Unwilling or unable to discontinue night shift work

Where it's running

  • Massachusetts General Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • APSTZD for Insomnia: Safety and Effectiveness in Adults

    This trial tests APSTZD against an active drug and placebo to see if it helps adults with insomnia.

    Recruiting Phase 2 Apsen Farmaceutica S.A. · Bragança Paulista, São Paulo · NCT07420816

  • Culturally adapted sleep education for older Korean immigrants

    This pilot tests a Korean-language, culturally adapted CBT-I sleep education program to see if it improves sleep for older Korean immigrants with chronic insomnia.

    Recruiting University of California, Los Angeles · Los Angeles, California · NCT07387406

  • Remote CBT-I with IoT and AI for Insomnia in Older Adults

    This trial tests if a fully remote, AI‑driven digital CBT‑I program with IoT environmental cues helps older adults with insomnia more than two active CBT‑I–based or sleep hygiene controls.

    Recruiting at 2 sites Phase 2 Proactive Life Inc · New York, New York and 1 other locations · NCT07316153

  • Trazodone for insomnia in adults 65 and older

    This trial will test whether taking low-dose trazodone at bedtime helps reduce insomnia symptoms in adults aged 65 and older compared with a placebo.

    Recruiting Phase 2 Centre hospitalier de l'Université de Montréal (CHUM) · Montreal, Quebec · NCT06983080

  • Bedtime mindfulness meditation for chronic trouble falling asleep

    This pilot will test whether a 4-week bedtime mindfulness app helps adults with chronic trouble falling asleep compared with an unguided meditation app or sleep hygiene education.

    Recruiting Phase 1/2 Brigham and Women's Hospital · Boston, Massachusetts · NCT06972303

  • Ba Duan Jin exercise for chronic insomnia with anxiety

    This study is testing whether practicing Ba Duan Jin, a traditional Chinese exercise, can help people with chronic insomnia and anxiety sleep better and feel less anxious compared to just getting sleep education.

    Recruiting Xuanwu Hospital, Beijing · Beijing · NCT06969079

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.